The previously unknown cause of anti-phosphatidylethanolamine (aPE) autoimmunity was discovered in a Northwestern Medicine study published in PNAS.
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
A newly announced American Heart Association research center will be led by Mary McDermott, MD, and focus on calf muscle pathology in peripheral artery disease.
Scientists are one step closer to a stem cell treatment for muscular dystrophy after Northwestern Medicine investigators demonstrated improvements in muscle tissue differentiation in stem cells.
A newly discovered gene mutation may increase a patient’s risk of genetic heart disease, presenting a target for therapy or genetic screening down the road.
Northwestern Medicine scientists have demonstrated the potential of targeting inflammatory pathways in order to limit tissue damage and improve repair after a heart attack.
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
An online calculator showed initial success at predicting the risk of heart disease events among young, healthy adults, according to a new study in JAMA Internal Medicine.
Poor sleep may be a significant factor driving the differences in risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study.
Mutations in the genes FOXC2 and GJC2 are associated with defects in venous valves, according to a new study published in the Journal of Experimental Medicine.